Hepatitis C: Part II. Prevention counseling and medical evaluation

American Family Physician

Volumn 59, Issue 2, 1999, Pages 349-354

  Moyer, Linda A ^a   Mast, Eric E ^a   Alter, Miriam J ^a  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; HEALTH PROGRAM; HEPATITIS C; HIGH RISK POPULATION; HUMAN; INFECTION PREVENTION; MAJOR CLINICAL STUDY; PATIENT COUNSELING; PREVALENCE; UNITED STATES; VIRUS TRANSMISSION;

ANTIVIRAL AGENTS; COUNSELING; HEPATITIS C; HUMANS; INTERFERONS; PATIENT EDUCATION; TEACHING MATERIALS;

EID: 0033555501     PISSN: 0002838X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Krawczynski K, Alter MJ, Tankersley DL, Beach M, Robertson BH, Lambert S, et al. Effect of immune globulin on the prevention of experimental hepatitis C virus infection. J Infect Dis 1996;173: 822-8.
2. Centers for Disease Control and Prevention, Public Health Service inter-agency guidelines for screening donors of blood, plasma, organs, tissues, and semen for evidence of hepatitis B and hepatitis C. MMWR Morb Mortal Weekly Rep 1991;40 (RR-4):1-17.
3. Centers for Disease Control and Prevention, Health Resources and Services Administration, National Institute on Drug Abuse, Substance Abuse and Mental Health Services Administration. Medical advice for persons who inject illicit drugs. HIV Prevention Bulletin, May 1997. Retrieved September 1998 from the World Wide Web: http://www. cdc.gov/nchstp/hiv_aids/pubs/hiv_prev.txt.
4. Centers for Disease Control and Prevention. Recommendations for prevention and control of hepatitis C virus (HCV) infection and HCV-related chronic disease. MMWR Morb Mortal Weekly Rep 1998;47(RR-19):1-39.
5. Centers for Disease Control and Prevention. Prevention of hepatitis A through active or passive immunization: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mortal Weekly Rep 1996;45(RR-15):1-30.
6. Centers for Disease Control and Prevention. Hepatitis B virus: a comprehensive strategy for eliminating transmission in the United States through universal childhood vaccination: recommendations of the Immunization Practices Advisory Committee (ACIP). MMWR Morb Mortal Weekly Rep 1991;40(RR-13):1-25.
7. Alter MJ, Mast EE, Moyer LA, Margolis HS. Hepatitis C. Infect Dis Clin North Am 1998;12:13-26.
8. Schiff ER. Hepatitis C and alcohol. Hepatology 1997;26(3 Supple 1):39S-42S.
9. Mast EE, Alter MJ. Hepatitis C. Semin Pediatr Infect Dis 1997;8:17-22.
10. Hepatitis Surveillance Report No. 56. Atlanta: Centers for Disease Control and Prevention, 1995:3-6.
11. National Institutes of Health Consensus Development Conference Panel Statement: management of hepatitis C. Hepatology 1997;26(3 Suppl 1):2S-10S.
12. Hoofnagle JH, Di Bisceglie AM. The treatment of chronic viral hepatitis. N Engl J Med 1997;336:347-56.
13. Fried MW. Therapy of chronic viral hepatitis. Med Clin North Am 1996;80:957-72.
14. Lok AS, Gunaratnam NT. Diagnosis of hepatitis C. Hepatology 1997;26(3 Suppl 1):48S-56S.
15. Poynard T, Leroy V, Cohard M, Thevenot T, Math-urin P, Opolon P, et al. Meta-analysis of interferon randomized trials in the treatment of viral hepatitis C: effects of dose and duration. Hepatology 1996: 24:778-89.
16. Reichard O, Schvarcz R, Weiland O. Therapy of hepatitis C: alpha Interferon and ribavirin. Hepatology 1997;26(3 Suppl 1):108S-111S.